CIK: 1426479 - Address: C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA 02210
2 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/1/16 20:28
7/29/16
ILIUInterleukin Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticDipalma Stephen J.MAOInterim P.d100.0994010140350D
12/30/14 14:23
12/23/14
ILIUInterleukin Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticDipalma Stephen J.MAOInterim P.d250.10030249New249D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact